本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 1994/1/201 分钟阅读
Regulations Review Program Under Executive Order 12866
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is announcing its plan to review significant regulations pursuant to Executive Order 12866, which requires all Federal agencies to develop a program for periodically reviewing existing significant regulations. Under this program, the agency will determine whether its regulations need to be refined to achieve their public health goals more effectively or to avoid unnecessary burdens.
来源原始语言: Federal Register — Health and Human Services打开原始公告 →